Home

Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)

0.8305
-0.0193 (-2.27%)
NASDAQ · Last Trade: May 17th, 7:17 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Shareholder Alert: Ademi LLP investigates whether Salarius Pharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders
Ademi LLP is investigating Salarius (NASDAQ: SLRX) for possible breaches of fiduciary duty and other violations of law in its transaction with Decoy Therapeutics.
By Ademi LLP · Via Business Wire · January 13, 2025